Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ahololooooololooooooooo, indeed. Today "Provista Diasgnostics has control of AMDL Diagnostics?" odd... just yesterday, RXPC shareholders controlled Radient Pharmaceuticals and AMDL Diagnostics. Things change fast in Big Pharma, don't they?
b]That means Provista has NO FURTHER REASON to merge with Radient. That IS big NEWSSSSSSSSSSSSSSS!
The Miami Dolphins are in Florida. Provista must own the Miami Dolphins too. Can we get Dan Marino to sign a "Rear in Gear" t-shirt?
The Aussies control AMDL Diagnostics. They have transferred the Trademarks out of Radient Pharmaceuticals into AMDL Diagnostics.
Did RXPC Shareholders approve the Trademark Transfer? Did RXPC Shareholders control these transactions? Do RXPC Shareholders have any say about what the Aussies do with Radient or its assets? Do RXPC shareholders benefit in aqny way from the transfer of Trademarks out of Radient Pharmaceuticals into any of the AMDL entities?
Answers: No, No, No, and No.
Regarding the statement "when Mac was CEO of Radient he could start a corporation and take all of RAdienta nd AMDL Diagnostics assets and stock and transfer it to his EWELLNESS corporation.." You are correct, as CEO he could do all that. if RXPC shareholders and/or lenders wanted retribution they would have to sue him and the company for "breaches of fiduciary duties of care, loyalty, good faith and disclosure, self dealing and waste and spoliation of corporate assets."
Sound familiar?
And nobody is saying the Aussies own RXPC stock or AMDL Diagnostics stock. RXPC stock is worthless so who cares who owns that... and the legal owner of AMDL Diagnostics stock is still Radient Pharmaceuticals as far as we know. Radient is an insolvent voided corporation that cannot conduct business and cannot legally object to whatever AMDL Diagnostics does.
The important thing to take away from the Trademark Transactions is: if anyone wants to pay licensing fees for the Trademark names, they pay those to AMDL, not Radient, preventing Radient's creditors and/or shareholders from sueing to retrieve the money. It's just business.
I want to hear about the smoke screen patent.
A merger theorist said:
"By the way..The Attorney for Radient resigned, you know the same attorney that resigned back in 2014 after the smoke screen patent was let go. "
Odd, there are dozens if not hundreds of posts here from 2013 and early 2014 that insist "it's all about the patent" and "we are just waiting for the patent" and "the patent will be approved ahoooolol." Now the patent application was just a smoke screen? and purposely "let go?"
IMO, that is just as absurd as saying "Radient voluntarily revoked share registration" and "Radient voluntarily admitted that the $20 million Jade Holding was actually worth $0." But that's just me. I am open to hearing about how that patent application was just another smokescreen.
There is so much smoke here, it's getting hard to tell where one smokescreen ends and another begins. It's suspiciously looking like a crash-and-burn to me.
guardiangel, you said:
"Bill White was just announced earlier this year(After March 1, 2015) as CEO.. "
Bill White signed as AMDL CEO on the trademark transfers on December 21, 2014.
http://assignments.uspto.gov/assignments/assignment-tm-5580-0634.pdf
http://assignments.uspto.gov/assignments/assignment-tm-5580-0640.pdf
Face it: the Aussies are in control and they are not going to resurrect Radient and RXPC Shareholders can't do anything about it.
guardiangel, you said in this post:
"please show where charter became CEO of AMDL Diagnostics Inc.? Unless you pay a few bucks to Delaware,you can not argue the fact that he is involved with AMDL Diagnostics Inc..We did pay the monies...Charter is not the CEO of AMDL Diagnostics Inc...Capiche? lol "
So you knew when you wrote this post that Bill White was CEO of AMDL Diagnostics?
Why does it matter WHICH Aussie is CEO of AMDL Diagnostics? The Aussies are working together and their current company is CST AMDL.
This just proves that Radient and AMDL Diagnostics are corpses, CST AMDL is the surviving entity, and the Aussies are controlling the entire show.
Capiche? LOL
Radient is ready for someone to play Taps.
Nothing else.
It's ludicrous to suggest that any entity would resurrect Radient and its $20 million debt with all 5 billion shares already issued.
The AMDL that received the trademarks is the AMDL that has Darren Brown as the email correspondent at CST, Bill White as the CEO, and the Tustin address. Those are the specs for the CST version of AMDL, not the USA version of AMDL.
CST AMDL is not a wholly owned subsidiary of Radient Pharmaceuticals. If someone resurrects Radient Pharmaceuticals now, they won't own those trademarks in their US AMDL subsidiary.
Will the Aussies enforce the trademarks against UNI or Arima or anyone else in Asia? Doubtful, because who cares? DR-70 and Onko-Sure are names associated with a failed product. CST AMDL was smart in abandoning those names in their new company.
RE: DR-70 trademark: the K&L Gates attorney withdrew.
https://trademarks.justia.com/776/64/dr-70-77664344.html
2015-08-27 TEAS WITHDRAWAL OF ATTORNEY RECEIVED
2015-08-27 WITHDRAWAL OF ATTORNEY GRANTED
It's tough to enforce a trademark if you don't have an attorney.
AMDL Inc. appears to have the same philosophy as Radient about paying attorney fees to K&L Gates, as in, why bother?
And let's talk about the re-assignment of trademarks from Radient to AMDL. Both DR-70 and ONKO-SURE trademarks have this line in the transaction history:
2015-07-29 AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Let's do a little DD for DR-70, shall we? read this:
http://assignments.uspto.gov/assignments/assignment-tm-5580-0634.pdf
And ONKO-SURE? Yes, let's do some DD:
http://assignments.uspto.gov/assignments/assignment-tm-5580-0640.pdf
Each trademark was recently re-assigned to AMDL Inc. The correspondence email Address is Darren Brown at CST, Charter signed as the CEO of Radient, and Bill White signed as the CEO of AMDL. Yes, the Aussies are controlling AMDL too, and they just transferred the trademarks away from Radient.
Filing for bankruptcy costs money. Radient had none.
Regardless, Filing for BK and/or shutting down operations (which, by the way, Radient did for all practical purposes at the end of 2012) does not make a class action lawsuit "go away." No matter what MacLellan did with Radient, he and Radient would have had to face the class action, and the insurance company would have had to pay.
This is the part I think the merger theorists don't seem to understand: it didn't matter what Radient's assets were for the class action because the settlement was paid by insurance, not by Radient.
You say "MacLellan could've done a lot of things?" I disagree - Radient had no money so his choices were limited. His only option, IMO, was to do nothing and ride it out, which is exactly what he did. MacLellan waited until the class action was resolved in 2014, and as soon as it resolved, literally within DAYS, he resigned from Radient and walked away with his jacket slung over his shoulder.
The only remaining questions at that point were: (1) what would happen to the final patent application, and (2) what would the new Officers and Directors do with Radient's assets, meager as they were?
We got the answer to (1) within a month -- in June 2014, the final patent application was rejected, which meant the UNI Agreement terminated and DR70 was off patent, opening the door for ANYONE to manufacture and market DR70 without paying Radient or AMDL a dime.
And we now have the answer to (2): the Radient Officers and Directors formed a new company called CST on the other side of the planet, and when the old RXPC shareholders found their new website and started asking questions, these Officers and Directors blocked all US ISP's from accessing the website. Could their intent be any clearer?
If "Arima already owns the shell" and plans to resurrect Radient, they have their work cut out for them. They have to force the Aussies to hand over the records so they can file the missing Radient financials, and then they have to file for bankruptcy and restructure to get rid of the $20 million lender debt. The only way the lenders might agree to THAT restructuring plan would be to cancel the existing RXPC stock and issue new shares to the lenders. Current RXPC shareholders would get nothing in the new company.
I see that some of the merger theorists claim that the lender debt was already resolved. That is ridiculous. $20 million debt doesn't just go away. When a company is struggling and insolvent, the first bills they try to pay are operational expenses like suppliers and vendors and utilities. Radient was unable to pay even THOSE expenses -- there is no possible way they paid off more than a small fraction of the lender debt.
So what is the best case scenario here? Arima resurrects Radient and does all that work to get an empty RXPC shell with the inherited lenders as new shareholders? That makes no sense. Arima could, and will, get a clean shell for much less effort and money.
Why would UNI merge into an OTC shell that has $20 million debt?
If UNI acquired RXPC stock, they could only have done so if the lenders dumped their shares. Which means the lender debt is still at LEAST $20 million.
UNI/Arima might merge into an OTC shell, but it won't be RXPC. The debt is prohibitive.
After November 2015, if Provista does not merge with Radient, will the "Merger Theorists" stop claiming that "Provista is under agreement with Radient?"
Just curious. I suspect the answer is NO -- the "Merger Theorists" will never stop claiming that Provista is under some sort of agreement with Radient. If the 2010 LOI must be abandoned, it can simply be replaced by a rumor of a secret agreement concealed by a smokescreen (and wrapped in a conundrum).
Personally, I think UNI-Pharma is blowing smoke up, er, well, into the air. Onko-Sure DR-70 is junk and they must be finally figuring that out. They can talk about a second generation and third generation DR-70, but Radient tried for over five years and failed, all the while hyping a New Generation of DR-70 just as hard as UNI is hyping it now.
And it matters not as far as RXPC shareholders are concerned. Anything UNI Pharma does in the future will have no effect on RXPC stock. RXPC stock is dead and gone forever. Stocks do not get any deader than RXPC. Pick any biotech stock that went bankrupt and/or disappeared in the last five years -- that stock has a better chance of trading again than RXPC.
What do you mean "It works better?"
Did you find Radient Pharmaceuticals as a resurrected corporation in a different state using CIK# 0000838879?
guardiangel said:
"Here is what I found so far...There is a corporation named Radient Pharmaceuticals Inc. Now one needs to know which state Radient Pharmaceuticals was resurrected in..A question the Wolf Pack mentioned in the past you understand..."
I doubt this to be true. I doubt there is another corporation in the USA named Radient Pharmaceuticals Inc. But I welcome the "Wolf Pack" to try and find one.
The Radient merger story is unraveling....
right before our eyes. With the snap of the fingers, Provista has finally been kicked to the curb.... only four years overdue, but the truth is difficult to accept sometimes.
Now the merger rumor shifts to Arima being the White Knight and owning the majority of shares. But that leaves no shares for the lenders, which means the lender debt has not been resolved.... so the Radient Pharmaceuticals shell is still $20 million in debt. That's kind of an unattractive shell, don't you think?
And all the posts -- literally thousands of them -- that insisted the lenders owned 31% and the Provista private shareholders owned 51% -- now we're admitting that those posts were just the figment of someone's imagination.
But if the Provista/Lender Ownership scenario was all a fabrication, then why should we believe this new scenario?
GCDx's lung cancer test is just DR-70.
GCDX didn't sell DR-70 to Provista. Nobody "owns" DR-70 now -- it's off patent. GCDx is trying to sell it, SRL apparently still has it for sale on their website, CSTAMDL is planning to sell it, UNI is trying to sell it, Arima is planning to sell it.... And anyone else who wants to try can sell it without paying royalties or licensing fees to anyone.
So Provista is no longer merging into Radient?
I just want to make sure I understand the latest revision of the takeover/merger rumor. Provista is OUT and UNI/Arima is IN?
Does this mean we are abandoning the Provista/Radient LOI of 2010?
Every post about the Provista/Radient LOI from 2011 through yesterday was, in fact, wrong?
This is indeed a revelation.
GCDx is not a subsidiary of Provista, wholly owned or otherwise.
GCDx is not working with Uni-Pharma and/or Pharmigene.
Nobody is merging into the Radient shell. There is no "Planned Reverse Merger."
Nobody wants control of CIT and nobody can have control of DR-70 because it's off patent.
Arima may be planning to manufacture and market DR70 but it won't help RXPC shareholders in any way.
A better name would be "Can't Be Sure."
The poor sensitivity/specificity makes it useless as a screener. Even MacLellan adnitted that in one of the conference calls.
That's why the FDA rejected the 510(k) twice and finally cleared the test as a CRC monitoring device ONLY.
Every entity trying to market DR-70 as a screener is trying to pull the wool over someone's eyes.
Nobody is worried about trademark infringement because the only entity that can sue them -- Radient -- is DEAD and GONE.
But who is marketing the test as onko-sure or DR-70 other than UNI though? GCDx is not and CSTamdl is not. Is it just UNI?
Let's pretend, then, that UNI is licensing the name "Onko-Sure" and/or "DR-70" from AMDL Inc. If Arima or Pharmigene or anyone else ever gets around to selling the test, and they want to use the names Onko-Sure or DR-70, they can license that from AMDL.
Every time an entity uses these trademarked names, the case for the Resurrection of Radient Pharmaceuticals, and with it RXPC stock, gets WORSE. MacLellan and Ariura have no reason to resurrect Radient Pharmaceuticals if they can get the licensing fees through AMDL and keep all the money themselves.
Pharmaline knows that DR70 is off patent.
GCDx knows this, UNI knows this, Arima knows this, and CSTamdl knows this. Odd that some RXPC shareholders apparently still do not know this.
These entities are all working with DR70 without licensing it from, or paying any royalties or fees to, Radient Pharmaceuticals. This is why Radient Pharmaceuticals died and RXPC stock is now worthless. If this is still not clear, let's list Radient's "assets" and what happened to those assets:
-> DR-70: Transferred to AMDL, Inc. and now off patent, so several entities around the globe are currently trying to test/manufacture/market it.
-> CIT: declared worthless and transferred to NuVax.
-> Jade Holdings: revealed to be worthless.
-> Publications and research: CST in Hong Kong, led by Radient CEO and Officers Charter and Brown, now claims these assets as their own.
What does Radient Pharmaceuticals have left? Nothing. Well, not assets anyway. They have 5 billion shares issued and they have about $20 million in debt and they have 2.5 years of missing SEC financial filings, but those are reasons NOT to merge with Radient, and we are trying to find reasons why Arima or Provista or ANYONE would want to merge with Radient.
Radient Pharmaceuticals no longer owns CIT.
All the CIT Assets were transferred to NuVax just as DR70 was transferred to AMDL. Read the final 10K for proof.
Not that it matters since CIT is worthless. If you read the SEC filings you will learn that Dr. Chang, the inventor of CIT, worked on CIT at NuVax for only two weeks before NuVax abandoned CIT and licensed Chang's newer work from the University of Florida.
If CIT's own inventor won't work on CIT, who will?
Oh and by the way, you do not own stock in UNIpharma. You own RXPC stock and it is worthless.
You don't own stock in AMDL Diagnostics.
You own RXPC shares, and they are worthless.
Did you notice that your story is from August 20, 2009? I have more recent news for you from 2014: RXPC share registration has been revoked and Radient Pharmaceuticals declared itself insolvent and disappeared. Then, in 2015, the Radient Officers and Directors resurfaced in Hong Kong with a new company called CST, and they are claiming all the Radient assets, IP, research, and publications as their own.
This brings up one of the major flaws in the merger/takeover rumors. The entities who supposedly accumulated over half of RXPC shares from 2011 through 2014 have no way of resurrecting RXPC. They must rely on someone else -- MacLellan, Ariura, Charter, or Brown -- to file the missing financials and resurrect the dead company.
That would be a poorly conceived takeover plan: buy and hold stock that you know is going to be revoked, relying on someone else to resurrect the stock and the company at a later date that apparently is years down the road, based on what would be a secret clandestine takeover deal initiated before revocation and therefore illegal since it would be a material event requiring the filing of Schedule 13's.
We know from Charter and Brown's new CST company that THEY have no intention of resurrecting Radient and RXPC stock. That leaves Ariura and MacLellan. Haven't we established that Ariura and MacLellan have moved on? Ariura has a full-time job at a toy company and MacLellan is spending all his time on eWellness.
That's only ONE of the flaws in the takeover rumors, but it's a big one. The "smokescreen excuse" might explain things to children, but we are adults here. Ariura's new job is not a smokescreen, eWellness is not a smokescreen, CSTAMDL is not a smokescreen, Radient declaring itself insolvent was not a smokescreen, and MacLellan and Ariura resigning from Radient was not a smokescreen. Each of these things proves that all the men capable of resurrecting RXPC stock have moved on, which means the entities and/or daytraders who currently own RXPC are out of luck.
I don't think AMDL USA is operating, but if it is, that just proves that the people involved bled Radient dry and discarded the empty husk. That would be terrible news for RXPC shareholders if MacLellan and Ariura transferred all the assets to AMDL and then abruptly resigned from Radient with the intent of continuing operations at AMDL. That would be one more piece of evidence that MacLellan has no intention of resurrecting Radient.
the Share Price proves you wrong about everything.
It doesn't matter who owns the 5 billion dead RXPC shares. They are worthless and they will remain worthless. And the Provista LOI was non-binding in 2010 in the first place -- and then both Provista and Radient said publicly that the LOI terminated.
A stock does not get any deader than this. Pick any biotech that has gone bankrupt or disappeared in the last five years and you will have a more likely candidate for a merger or takeover than Radient.
RXPC stock is dead and buried and Radient Pharmaceuticals is dead and buried. The Radient Officers and Directors resurfaced in Hong Kong claiming all of Radient's IP, Assets, and Research as their own - that was the last piece of the puzzle. There are no more secrets or mysteries here.
You are confused.
The lenders received about 4 billion shares from Radient in the "debt to equity swap." that was never in contention. The REGSHO list clearly proved that.
The REGSHO list also proved that they dumped those shares immediately without ever taking them into posession.
The lenders never held RXPC shares any longer than absolutely necessary, which was less than one day. Radient's lenders did not own any shares the day RXPC share registration was revoked.
The assertion that the lenders sold shares on the open market for a takeover entity to scoop up is preposterous.
Every piece of the Creeping backdoor merger rumor is shrouded in secrecy and protected by some strange "it can't be 100% proven wrong so it must be 100% right" logic. That kind of logic results in the investor losing money. RXPC stock is the poster child for what happens when people invest in stocks without doing their own DD.
The RXPC account value in every RXPC shareholder's brokerage account tells the complete story of Radient Pharmaceuticals. RXPC is worth zero.
The lenders got what little they could out of the "debt to equity swap" by taking shares from Radient and dumping them on the open market every time RXPC was manipulated.
I'd guess that resolved about $1 million of their $20 million debt, TOPS.
The lenders were swindled, IMO, when Radient claimed they had $20 million equity in Jade as collateral for the loans. But what could the lenders do about it? That $1 million was more than Radient would have given them in a lawsuit after filing for bankruptcy as MacLellan threatened to do.
One set of merger rumor mongers says the lenders and Provista Angel Investors own 90% of revoked RXPC shares. Another merger rumor monger says Arima owns 51% of revoked RXPC shares. I say all 100% of revoked RXPC shares are owned by retail bagholders who were too ignorant and/or too stubborn to sell at the end.
Shareholders have the right to ask the company for a list of all shareholders. Unfortunately, this company disappeared, so it's all conjecture.
So I ask again: when will the rumor mongers accept that RXPC shares are dead and gone forever? When Provista and Arima both go public without involving RXPC -- will that do it? Or will the merger rumor mongers simply find a new White Knight to plug into the rumors?
Astellas hasn't been mentioned in awhile..... their silence is apparently all the proof anyone needs to name them as the New Savior of Radient. Must we wait for Provista and Arima to go public?
In 2013-2014, virtually every zombie pinksheet biotech was manipulated by entrepeneurs (for lack of a better word) who tweeted "Weed Play!" knowing that the zombie companies would not refute the rumor. This happened to RXPC at least three times. Each time, the volume was in the hundreds of millions, but the PPS stalled at .0004.
On those high volume days, who kept dumping? Why was there so much selling pressure? Regardless of who was buying -- who had billions of shares to sell, and why didn't those sellers know about the "secret merger/takeover?"
The day after every one of those high-volume days the REGSHO list showed millions of unresolved RXPC shares. The VERY NEXT DAY those shares were off the REGSHO list. This proves that Radient was issuing new shares to some entity who promptly dumped them on the open market.
This massive dumping kept the PPS from rising above .0004 on those high-volume days. What explanation could there possibly be for such massive dumping? I think we all agree that the billions of new shares were going to the lenders in the infamous "debt to equity swap" plan.... so why didn't the lenders hold those shares?
Fast forward to August 2015. RXPC has been rotting in the grave for over a year and the Radient Officers and Directors, missing for a year, have resurfaced in Hong Kong claiming all the Radient IP, research, and publications as their own. Why is this not enough to quell the Radient takeover/merger/resurrection rumors?
At what point will everyone admit that RXPC shares are dead and gone forever? When Provista and Arima both go public without involving RXPC, will that end the takeover/merger/resurrection rumors? Or will they never end?
Let's summarize the merger/takeover rumors. Radient was deep in debt and some entity wanted to take it over, so instead of just working a new deal with the lenders, they devised a plan in which Radient sabotages the PPS and the company, gives away Asia sales to UNI, gets delisted to the pinksheets, issues 4.5 billion new shares, ceases operations, and then when all the shares are issued REVOKES SHARE REGISTRATION and disappears.
That would be the stupidest takever plan I've ever seen.
Answer the question. Why the secrecy?
What does anyone have to gain by keeping the Radient reverse backdoor creative creeping sideways hostile friendly merger A SECRET?
I'm having trouble following the money.
It looks to me like the money disappeared. I think RXPC shares are now worthless.
I find it VERY hard to believe that any professional trading entity - hedge fund, lender, Arima, Provista Angel Investors, WHOMEVER the current flavor-of-the-month White Knight might be -- would buy this stock and hold it through registration revocation in 2014 and now own worthless shares. That seems ludicrous, to me.
I'm surprised ANYONE would hold a pinksheet pennystock after the company announced its insolvency and its intent to revoke share registration. Yes, SOMEONE had to be left holding the bag, but some Twittering eBabies had buy orders in right to the day of revocation. True, those buys were only for .0001 and they were only for about 300 million shares, but that's $30,000 and $30,000 would have been better than $0
The English in that link is a bad translation. Those statements can't be accepted literally. You'd have to understand Mandarin and read the original release to know what UNI is really saying.
http://www.bioclub.com.tw/en/mediaExhibitorNewsDetail.asp?id=551
Here are a few quotes from that release:
"Cervi-M is developed by iStat and distributed by Uni Pharma since September 2015. "
How nice, they invented time travel.
"This test has granted patents in US , Taiwan and China."
Amazing. Usually it's the patent organization that grants patents, not the device itself.
"Simply using the cells from Pap smear sample residual and amply cell signal by real-time PCR ( Polymerase Chain Reaction) instrument to detect the methylated DNA."
Clear as mud.
"Since 2013, Uni Pharma successfully in-licensed DR-70®ELISA Test from USA and co-developed with Pharmigene. With great effort from Uni Pharma and Pharmigene, Taiwan-made DR-70®test passed TFDA and SGS audit and proudly received GMP and ISO 13485 certificate in March 2014. Furthermore, DR-70®receives Taiwan FDA marketing approval in August 2014 and CE certificate in September 2014."
That is the OLD formulation of DR-70. There's nothing new about that. and they are merely saying they initially licensed DR-70 in 2013, not that they are still paying a royalty fee to anyone.
"DR-70®( licensed by Uni Pharma is approved by US FDA for colorectal cancer monitoring in 2008 and it is the only tumor marker approved for colorectal cancer monitoring by FDA since 1985. "
For one thing, it's not cleared by the FDA any more -- Radient didn't pay the fees to keep it current. But more important: this is not proof that UNI is paying royalty fees to anyone in 2015. Who knows what they really said in Mandarin? WE don't. I choose to believe the legal contract in the SEC filing over a poorly translated press release.
Nice try though. Keep that dream alive. The Wolfpack still loves their wolfman, I'm sure. I hope they don't check the account value for RXPC in their brokerage accounts though -- that would be difficult to rationalize.
Ariura's new job must be a smokescreen.
The Creative Creeping Backdoor Merger theory asserts that Ariura is Secretary of Radient Pharmaceuticals (and probably CFO of AMDL Diagnostics). Since Radient is about to become a multi-billion-dollar SuperPharma that controls the Global Cancer Diagnostics arena, Ariura would never have time to work as CFO at a Toy Company.
I like the Smokescreen excuse - it works for everything.
guardiangel you said:
"Here is the proof that the New Generation DR-70 has been Developed"
Developed by whom? Where is this proof? I don't see any proof. Please be specific. Is it the statement "Other countries like Korea, China are under regulatory filing and expect to receive approval by Q4 2015 and 2017, respectively?" Sorry that is the same old DR-70, not a new formulation, you understand.
guardiangel you said:
"AMDL Diagnostics and Uni-Pharma agreement still in force..The dis tractors think different..That is because they don't know how to read and interpret agreements you understand"
You do NOT understand. The agreement CLEARLY states that the agreement terminates when the last DR70 patent expires, which happened. That means the UNI agreement terminated. There is no gray area here. This is in black and white, you understand.
guardiangel you also said:
"Also the aussies web site can not be found on foreign servers, if so the person who posted that silly premise would have posted the changes by paste and copy instead of making up the differences you understand..lol OK? "
You do NOT understand. Anyone, including you, can access the cstAMDL.com website through a non-USA proxy, you understand. If you doubt this, take three minutes of your time and try it.
The two merger theories contradict each other. The only thing they have in common: they are both absurd.
One theory has some private investors owning a majority in both Provista and Radient. These "Angel Investors" supposedly sabotaged Radient Pharmaceuticals over four years so they could buy shares cheaper. They will now apparently force Provista to merge with Radient.
The other theory has Arima owning a majority of Radient and UNI still paying $100,000 per year to AMDL Diagnostics even though they are no longer contractually requried to do so. The prize here for both Arima and UNI: DR-70, a tumor marker that the global medical community rejected and is now off patent.
And in both cases, $20 million debt is waiting for any prospective new owner of Radient Pharmaceuticals. The "Provista theory" claims that the debt magically disappeared because the lenders felt magnanimous, while the "Arima theory" simply pretends that debt doesn't exist.
LOL, indeed.
The expiration of the last DR70 patent terminated the UNI Agreement.
Charter and Green are "irrelevant?" LOL.
cstAMDL.com can be accessed.
that website is alive, online, and being maintained and edited.
It is simply blocked to all who have a USA ISP. You can visit that site f you use a non-USA proxy.
Now why do you suppose the Radient Pharmaceuticals CEO and CFO blocked that cstAMDL site from Americans?
LOL, Indeed. That sums it up here.
I can only imagine how the Aussies are ROF LOL as they read this nonsense.
jimtash you said:
"And even more telling, lots and lots of chatter for a delisted stock. LOL."
I posted a lot of messages in the last two weeks. The reason: I found the Aussies' website cstAMDL.com. That website is all the evidence we need to know that the Aussies took the assets of Radient and kicked Radient to the curb.
-> The Aussies do not want Radient to come back to life.
-> Radient cannot come back to life unless the Aussies allow it.
As far as I'm concerned, this finally puts an end to the debate about whether Radient Pharmaceuticals is dead. Yes, I was surprised to find that the "Investigative Longs" still have confidence that the reverse backdoor creative friendly creeping merger is not only still POSSIBLE, it is INEVITABLE and PROCEEDING AS PLANNED.
But in retrospect, I should not have been surprised. The backdoor merger rumor can weather any storm. If MacLellan or Charter or God released a PR saying "there is no merger," the Investigative Longs would simply shout "SMOKESCREEN!"
Every zombie biotech starts their hype PR's with a line like "the cancer diagnostics arena is expected to be worth $5 trillion in 2017."
To say that makes Radient stock more valuable is called a false enthymeme. Look it up.
pinksheet biotechs trading at .0001 get manipulated every day. RXPC went higher in 2014 on the "Weed Play" Tweet than it did in Feb 2013 on the "SRL is selling DR70 in India" hype.
The answer to your question "why did the RXPC PPS spike in Feb 2013?" is "SRL was hyping a DR70 rollout in India in February 2013."
And how did that turn out? A dud, just like every other DR70 hype since the hype started in 1996 in Brazil.
The market cap of this company when it crashed and burned was $500,000.
$500,000. My god.
I can guarantee with dead moral certainty that Provista shareholders didn't own one single share of toxic RXPC stock when share registration was revoked.
I am just now really looking at this "Angel Investors own both Radient and Provista stock and want to merge the companies" story. My god. It's too stupid to really discuss, isn't it? Private shareholders of Provista want to merge their little gem of a company with Toxic Radient in some kind of crazy hostile shareholder takeover? Add 5 billion issued shares and $20 million debt to the Provista balance sheet, and for that Provista gains.... AMDL Diagnostics, a company with no protected IP and nothing in the pipeline?
Reese and every single Provista officer and BOD member would quit on the SPOT.
The "Angel Investors" would then own stock in (a) debt-ridden revoked Radient and (b) leaderless Provista.
I'm sorry but I didn't realize until today what the main premise of this "Provista and Radient merger" theory was. I couldn't bring myself to sink into the depths of absurdity that this premise requires -- until now.
According to this theory, Provista isn't taking over Radient, because Provista doesn't own any RXPC shares. Instead, a bunch of apparently insane "Angel Investors" who destroyed Radient by sabotaging the PPS are now bent on destroying Provista, throwing away millions of their dollars in the process.
I'd laugh out loud if I wasn't aghast. I have to think the Aussies are rolling on the floor and weeping with derisive laughter as they read this stuff.
the Radient debt is $20 million or more.
We have no idea how much penalty/default/contractual interest has accrued because the lights are out and nobody's home.
Explain again why you think the "Provista Angel investors" own so many worthless shares of RXPC? Apparently they intend to force Provista and Radient together in a hostile takeover? And what do they gain from this, since DR-70 is already off patent and available to anyone who wants it?
Forcing these two companies together would destroy Provista and do nothing for Radient. So why are they doing this?
Is it because MacLellan wants to exercise some 10-cent options? Wasn';t that the big reason cited before?
These "Angel Investors" are not on the BOD of either company and they are not officers at either company. What are the steps of their merger plans, exactly?
LOL, another smokescreen.
It's difficult to see the Radient merger through all this smoke. According to the Radient Merger Theorists, every company and every CEO involved in this "creative backdoor reverse creeping merger" is misrepresenting their company and their intentions. They apparently list employees on their websites who don't work for them, ask for crowdsourcing money with fraudulent campaigns, and lie to interviewers.
Not to mention the way they issued 5 billion shares and then revoked registration of those shares, took down the websites, disconnected the phones, and disappeared behind a screen of smoke.
And the Radient Merger theorists think that investing in companies that deceive in this manner is a good idea. This, in their minds, was, and is, a STRONG buy.